Press release

Automata Technologies appoints advisory board of senior health and life sciences industry executives

New board will include former NHS England Chairman and leaders in biopharma, healthcare and clinical research organisations.

London, UK — 25 April 2024, Automata Technologies, a leading automation company powering automation in the life sciences labs, has appointed its first advisory board, consisting of senior global healthcare and life sciences industry executives. The board’s role will be to advise Automata’s board and senior leadership team on commercialisation strategy and to provide key industry insight and guidance in each of their target subsectors.

This appointment comes after Automata Technologies raised $40M in investment in a funding round last October, led by Dimension Capital with participation from A.P. Moller Holding, the parent company of the A.P. Moller Group and owners of, amongst other businesses, laboratory testing group Unilabs. Healthcare investor and industry specialist Joe Stringer was also appointed Automata Executive Chairman and Director of Corporate Development (EMEA) in November, signalling the start of Automata’s expansion drive.  

The advisory board will include Dr Sy Pretorius, former CMO at Parexel and now COO of US outsourced life sciences solutions provider Eversana; former NHS England Chair, Lord Prior of Brampton; and senior biotech leader Dr Annalisa Jenkins.

Board members span both private and public sectors and include senior leaders from pharmaceuticals, healthcare, regulatory affairs, scientific research, and international trade. It’s the ambition of this board to advise Automata on its journey to make automation technologies accessible to all laboratories seeking to develop and deliver life-changing treatments to patients faster.

Mostafa Elsayed, Co-Founder and CEO of Automata, commented:

Attracting this impressive group of senior advisors from across our key sectors of healthcare, biotech, pharma and outsourcing is a great validation for Automata and the potential that our technology can unlock for the industry.
These senior industry players will bring invaluable insight and advice as we continue to accelerate our growth and industry presence, ultimately helping to solve the challenges life sciences labs face today.


Automata Technologies
Mostafa Elsayed, Chief Executive Officer
+44 (0)20 3991 2253
Rozi Morris+44 (0)7740 859962

The Advisory board

The Advisory board includes Lord David Prior, Dr Annalisa Jenkins, and Dr Sy Pretorius. Find out more about them here.

About Automata

Automata’s mission is to enable labs in the life sciences industry to scale output and improve the quality of their experimental data by liberating scientists from time-consuming and error-prone manual tasks. Automata partners with life science companies across the globe to automate their workflows from end-to-end via our lab automation platform, LINQ.

Automata is trusted by customers, including the NHS, Health Services Laboratory, The Francis Crick Institute, BitBio and others. It supports advancements across healthcare genomics, CROs/CDMOs, pharma, biotech and academic institutes

Our socials